Sotabase
Home
Researchers
Career
·
Software Infrastructure Engineer
,
SpaceX (Starlink)
2025–2026
·
Software Engineer
,
Supermicro
2023–
Publications
(16)
High Plus Low Dose Radiation Strategy in Combination with TIGIT and PD1 Blockade to Promote Systemic Antitumor Responses
Cancers · 2022
37
cited
Novel Use of Low-Dose Radiotherapy to Modulate the Tumor Microenvironment of Liver Metastases
Frontiers in Immunology · 2021
27
cited
Nanoparticle-enhanced proton beam immunoradiotherapy drives immune activation and durable tumor rejection
JCI Insight · 2023
18
cited
NLRP3 agonist enhances radiation-induced immune priming and promotes abscopal responses in anti-PD1 resistant model
Cancer Immunology and Immunotherapy · 2023
16
cited
NBTXR3 improves the efficacy of immunoradiotherapy combining nonfucosylated anti-CTLA4 in an anti-PD1 resistant lung cancer model
Frontiers in Immunology · 2022
15
cited
Pulsed Radiation Therapy to Improve Systemic Control of Metastatic Cancer
Frontiers in Oncology · 2021
11
cited
Bone morphogenetic proteins, activins, and growth and differentiation factors in tumor immunology and immunotherapy resistance
Frontiers in Immunology · 2022
8
cited
Enhanced tumor control and survival in preclinical models with adoptive cell therapy preceded by low-dose radiotherapy
Frontiers in Oncology · 2024
8
cited
Systemic AAV9.BVES delivery ameliorates muscular dystrophy in a mouse model of LGMDR25
Molecular Therapy · 2022
7
cited
Novel engineered IL-2 Nemvaleukin alfa combined with PD1 checkpoint blockade enhances the systemic anti-tumor responses of radiation therapy
Journal of experimental & clinical cancer research : CR · 2024
5
cited
Pulsed radiotherapy to mitigate high tumor burden and generate immune memory
Frontiers in Immunology · 2022
5
cited
The RadScopal Technique as an Immune Adjuvant to Treat Cancer
Immuno · 2023
5
cited
Radiation Therapy Modulates Tumor Physical Characteristics to Reduce Intratumoral Pressure and Enhance Intratumoral Drug Delivery and Retention
Advances in Radiation Oncology · 2022
3
cited
869 NBTXR3-enhanced proton beam immunoradiotherapy reshapes tumor immune microenvironment and improves abscopal effect in an anti-PD1-resistant lung cancer
Regular and Young Investigator Award Abstracts · 2022
Correction: Novel engineered IL-2 Nemvaleukin alfa combined with PD1 checkpoint blockade enhances the systemic anti-tumor responses of radiation therapy
Journal of experimental & clinical cancer research : CR · 2024
Sotabase
Ethan Hsu | Researcher Profile | Sotabase | Sotabase